Literature DB >> 21428747

Behçet disease in children.

Leyla Atmaca1, Ayse Boyvat, F Nilüfer Yalçındağ, Pelin Atmaca-Sonmez, Aysel Gurler.   

Abstract

PURPOSE: To investigate the incidence and clinical characteristics of Behçet disease in children.
METHODS: The authors retrospectively reviewed the charts of 3382 patients with Behçet disease from October 1986 to December 2005 at Ankara University Medical School Behçet Unit and/or Atmaca private clinic.
RESULTS: 110 children were diagnosed with Behçet disease. The 110 children represented 3.3% of the total number of Behçet patients that were reviewed. 62.7% were girls and 37.3% were boys. The mean age at initial manifestation was 11.63 ± 3.46 years and at diagnosis was 14.15 ± 2.13 years. Ocular involvement was found in 30.9% of the children. Of these, 61.8% were bilateral and 38.2% were unilateral. Anterior uveitis was found in 18 eyes (32.8%), posterior uveitis in 24 eyes (43.6%), and panuveitis in 13 eyes (23.6%).
CONCLUSION: Behçet disease should be considered in the differential diagnosis of childhood uveitis, particularly in endemic areas. The collaboration of pediatricians, rheumatologists, dermatologists, ophthalmologists, and other specialists when necessary is required in the diagnosis and management of children with Behçet disease.

Entities:  

Mesh:

Year:  2011        PMID: 21428747     DOI: 10.3109/09273948.2011.555592

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  16 in total

Review 1.  Diagnostic/classification criteria in pediatric Behçet's disease.

Authors:  Ezgi Deniz Batu
Journal:  Rheumatol Int       Date:  2018-11-14       Impact factor: 2.631

2.  Serum vitronectin levels in patients with Behçet's disease.

Authors:  Ali Yalçındağ; Aslıhan Uzun; F Nilüfer Yalçındağ; Namık Delibaş
Journal:  Inflamm Res       Date:  2012-07-19       Impact factor: 4.575

Review 3.  Pediatric Behçet's disease - clinical aspects and current concepts.

Authors:  Mehmet Yıldız; Oya Köker; Amra Adrovic; Sezgin Şahin; Kenan Barut; Özgür Kasapçopur
Journal:  Eur J Rheumatol       Date:  2019-09-05

Review 4.  Clinical Manifestations and Management of Pediatric Behçet's Disease.

Authors:  Ya-Chiao Hu; Bor-Luen Chiang; Yao-Hsu Yang
Journal:  Clin Rev Allergy Immunol       Date:  2021-10       Impact factor: 8.667

Review 5.  Current perspectives on ophthalmic manifestations of childhood rheumatic diseases.

Authors:  Neal V Palejwala; Steven Yeh; Sheila T Angeles-Han
Journal:  Curr Rheumatol Rep       Date:  2013-07       Impact factor: 4.592

6.  Adalimumab in Treatment of Uveitis in Pediatric Behcet's Disease-a Case Report.

Authors:  Meliha Halilbasic; Amra Nadarevic Vodencarevic; Almira Cosickic; Amir Halilbasic; Arnes Cabric
Journal:  Mater Sociomed       Date:  2021-03

7.  A national cohort study on pediatric Behçet's disease: cross-sectional data from an Italian registry.

Authors:  Romina Gallizzi; Caterina Pidone; Luca Cantarini; Martina Finetti; Marco Cattalini; Giovanni Filocamo; Antonella Insalaco; Donato Rigante; Rita Consolini; Maria Cristina Maggio; Adele Civino; Silvana Martino; Alma Nunzia Olivieri; Giovanna Fabio; Serena Pastore; Angela Mauro; Diana Sutera; Giuseppe Trimarchi; Nicolino Ruperto; Marco Gattorno; Rolando Cimaz
Journal:  Pediatr Rheumatol Online J       Date:  2017-12-21       Impact factor: 3.054

8.  Early administration of adalimumab for paediatric uveitis due to Behçet's disease.

Authors:  Tomona Hiyama; Yosuke Harada; Takehiko Doi; Yoshiaki Kiuchi
Journal:  Pediatr Rheumatol Online J       Date:  2019-06-10       Impact factor: 3.054

Review 9.  Neuro-Behçet's disease in childhood: a focus on the neuro-ophthalmological features.

Authors:  Paolo Mora; Chiara Menozzi; Jelka G Orsoni; Pierangela Rubino; Livia Ruffini; Arturo Carta
Journal:  Orphanet J Rare Dis       Date:  2013-01-29       Impact factor: 4.123

Review 10.  Behçet's disease in children, an overview.

Authors:  Isabelle Koné-Paut
Journal:  Pediatr Rheumatol Online J       Date:  2016-02-18       Impact factor: 3.054

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.